XLP

Clinical trials for XLP explained in plain language.

Never miss a new study

Get alerted when new XLP trials appear

Sign up with your email to follow new studies for XLP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New pill aims to let sunlight-sensitive patients enjoy the sun longer

Symptom relief Completed

This study tested a drug called MT-7117 in 184 people aged 12-75 with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP), conditions that cause severe pain from sunlight. The goal was to see if the drug could delay the first signs of sun-related discomfort (burn…

Matched conditions: XLP

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief

Last updated May 12, 2026 13:42 UTC

XLP

Get alerted when new XLP trials appear

New pill aims to let sunlight-sensitive patients enjoy the sun longer